We will contact you shortly.
A unique opportunity to participate in the innovative treatment of ENS using an exosome-containing product.
Our specialists will be able to answer all your questions about the production of cells and the features of their use in various situations.
GOOD CELLS is resuming our charity project to help Ukrainian wounded soldiers and civilians. "You are fighting for our freedom - we are fighting for your health!"
The GOOD CELLS works in normal mode and provide full medical services to patients from Ukraine and residents of other countries who stay in the capital.
What properties make MSC exosomes a promising tool for the treatment of many diseases? Are exosomes safe? Read the article.
What are the advantages and disadvantages of MSC exosomes? What is the difference between MSC therapy and exosome therapy? Information is in the article.
What advantages do exosomes have over other cellular products? What clinical studies of their effectiveness are conducted in the world? Read the article.
Exosomes are a revolutionary biotech product for hair loss treatment. What are exosomes? What do exosomes consist of? Read about this in the article.
Information about the effect of ENS on the nervous and immune systems, the explanation of the need of taking prescribed drugs.
Our specialists gathered important information about ENS treatment process, prognoses and some additional recommendations.
A well-known international journal “World Journal of Stem Cells” published our scientific article on approaches to the ENS treatment.
Important information for patients with ENS about the first and following consultations with our doctors.
Our experts have determined the type of cells that are best suited for use in a three-component graft for the treatment of ENS.
Based on the experience of using a graft, a team of our specialists has formed 4 principles-recommendations for the treatment of ENS.
Testing of new three-component material in experimental conditions in vitro. The start of the experiment on animals.
Selection of synthetic inert material and a biological component of the graft to restore nasal tissues' volume and function in ENS patients.
A project for Ukrainians with degenerative, neurodegenerative, and autoimmune diseases who are in need of stem cell treatment.
In the future, the development may help solve the problems associated with the loss of connective tissue volume of the nasal concha.
Our partner's speech at the conference "Medical Trichology: What's New?".